Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Ceftazidime for Injection and Sodium Chloride Injection

Approval Number

国药准字H20205047

Company北京锐业制药有限公司

Registration Date

April 23, 2024

Previous Approval Numbers

国药准字H20193106

Drug Information

Generic Name

注射用头孢他啶/氯化钠注射液

Dosage Form

注射剂

Strength

粉体室:按头孢他啶（C₂₂H₂₂N₆O₇S₂）计1.0g；液体室：氯化钠注射液100ml:0.9g

Drug Type

化学药品

Registration Date

April 23, 2024

Company Information

Applicant Company

Company Name北京锐业制药有限公司

Company Address

北京市北京经济技术开发区隆庆街12号

Manufacturing Company

Company Name

北京锐业制药有限公司;北京锐业制药(潜山)有限公司

Company Address

北京市北京经济技术开发区隆庆街12号；安徽省潜山市皖国东路0012号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy